Wire Stories

Category Added in a WPeMatico Campaign

takeda_logo

Takeda’s EXKIVITY® (mobocertinib) Receives Approval from the NMPA of China, Becoming the First and Only Therapy Available for Patients with EGFR Exon20 Insertion+ NSCLC

logo-61

Assessment of India’s EdTech Sector 2023: Featuring Byju’s, Eruditus, Lead, PhysicsWallah, Unacademy, Upgrad & Vedantu – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Assessment of India's EdTech Sector 2023" report has been added to ResearchAndMarkets.com's offering. India has one of the...